Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer’s disease: a randomized, double-blind study

Cortical excitability can be modulated using repetitive transcranial magnetic stimulation (rTMS). Previously, we showed that rTMS combined with cognitive training (rTMS-COG) has positive results in Alzheimer’s disease (AD). The goal of this randomized double-blind, controlled study was to examine the safety and efficacy of rTMS-COG in AD. Fifteen AD patients received 1-h daily rTMS-COG or sham treatment (seven treated, eight placebo), five sessions/week for 6 weeks, followed by biweekly sessions for 3 months. The primary outcome was improvement of the cognitive score. The secondary outcome included improvement in the Clinical Global Impression of Change (CGIC) and Neuropsychiatric Inventory (NPI). There was an improvement in the average ADAS-cog score of 3.76 points after 6 weeks in the treatment group compared to 0.47 in the placebo group and 3.52 points after 4.5 months of treatment, compared to worsening of 0.38 in the placebo (P = 0.04 and P = 0.05, respectively). There was also an improvement in the average CGIC score of 3.57 (after 6 weeks) and 3.67 points (after 4.5 months), compared to 4.25 and 4.29 in the placebo group (mild worsening) (P = 0.05 and P = 0.05, respectively). NPI improved non-significantly. In summary, the NeuroAD system offers a novel, safe and effective therapy for improving cognitive function in AD.

[1]  E. Khedr,et al.  Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer’s dementia , 2011, Journal of Neurology.

[2]  Michal Lavidor,et al.  Lexical ambiguity resolution in Wernicke's area and its right homologue , 2009, Cortex.

[3]  S. Lisanby,et al.  Applications of Transcranial Magnetic Stimulation to Therapy in Psychiatry , 2004 .

[4]  Jonathan Bentwich,et al.  Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept study , 2011, Journal of Neural Transmission.

[5]  L. Voronin,et al.  Long-term potentiation in the hippocampus , 1983, Neuroscience.

[6]  J. Birks,et al.  Cholinesterase inhibitors for Alzheimer's disease. , 2006 .

[7]  J. Corey-Bloom,et al.  Clinical Adult Neurology , 2008 .

[8]  Bruce Luber,et al.  Transcranial magnetic stimulation: applications in basic neuroscience and neuropsychopharmacology. , 2000, The international journal of neuropsychopharmacology.

[9]  J. Cummings,et al.  The Neuropsychiatric Inventory , 1997, Neurology.

[10]  Alexandra J. Fiocco,et al.  Exercising the brain to avoid cognitive decline: examining the evidence , 2010 .

[11]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[12]  Guoyao Wu,et al.  Beneficial effects of l-arginine on reducing obesity: potential mechanisms and important implications for human health , 2010, Amino Acids.

[13]  Alex Martin,et al.  Lateralized spatial and object memory encoding in entorhinal and perirhinal cortices. , 2009, Learning & memory.

[14]  Á. Pascual-Leone,et al.  Noninvasive human brain stimulation. , 2007, Annual review of biomedical engineering.

[15]  William Matchin,et al.  Broca's Area, Sentence Comprehension, and Working Memory: An fMRI Study , 2008, Frontiers in human neuroscience.

[16]  M. Hallett,et al.  Induction of a recall deficit by rapid-rate transcranial magnetic stimulation. , 1994, Neuroreport.

[17]  Mbbs,et al.  Hormonal Treatments for Women With Schizophrenia , 2004 .

[18]  Eugen Trinka,et al.  Effect of Transcranial Brain Stimulation for the Treatment of Alzheimer Disease: A Review , 2011, International journal of Alzheimer's disease.

[19]  Mark A Frye,et al.  Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism , 1999, Biological Psychiatry.

[20]  A. Wieraszko,et al.  Modulation of learning and hippocampal, neuronal plasticity by repetitive transcranial magnetic stimulation (rTMS) , 2006, Bioelectromagnetics.

[21]  M. Buchsbaum.  Regional cerebral blood flow changes in drug-resistant depressed patients following treatment with transcranial magnetic stimulation: a statistical parametric mapping analysis. , 2002, Psychiatry research.

[22]  K. Davis.  Cholinesterase Inhibitors in Alzheimer's Disease , 1994, Neuropsychopharmacology.

[23]  Carlo Miniussi,et al.  Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. , 2006, Archives of neurology.

[24]  V. Lazzaro,et al.  Physiology of repetitive transcranial magnetic stimulation of the human brain , 2010, Brain Stimulation.

[25]  Alvaro Pascual-Leone,et al.  Noninvasive brain stimulation in Alzheimer's disease: Systematic review and perspectives for the future , 2011, Experimental Gerontology.

[26]  C. Miniussi,et al.  Improved language performance in Alzheimer disease following brain stimulation , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[28]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[29]  D. Jeste,et al.  Cognitive training in Alzheimer's disease: a meta‐analysis of the literature , 2006, Acta psychiatrica Scandinavica.

[30]  J. Rothwell,et al.  Transcranial magnetic stimulation: new insights into representational cortical plasticity , 2002, Experimental Brain Research.

[31]  Á. Pascual-Leone,et al.  Study and modulation of human cortical excitability with transcranial magnetic stimulation. , 1998, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[32]  S. Fay,et al.  The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial , 2007, BMC neurology.

[33]  S. Rossi,et al.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research , 2009, Clinical Neurophysiology.

[34]  S. Black,et al.  Spatial-and object-based attentional deficits in Alzheimer''s disease , 1997 .

[35]  Bob Woods,et al.  Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia , 2003, British Journal of Psychiatry.

[36]  J. Raftery,et al.  Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial , 2004, The Lancet.

[37]  G. Blessed,et al.  NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA , 1977, The Lancet.